Overview of Tirzepatide 10mg
Tirzepatide 10mg is a dual-acting agent targeting the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It is designed to interact with key metabolic pathways involved in glucose regulation and energy balance. Current research is exploring the drug’s potential effects on glucose metabolism, insulin sensitivity, and weight management, with particular interest in how dual receptor activation influences metabolic efficiency and nutrient regulation. Consequently, Tirzepatide has become a focal point of ongoing studies in the fields of metabolic and endocrine research.
The compound used in this study is manufactured in state-of-the-art facilities adhering to Good Manufacturing Practice (GMP) guidelines to ensure consistency and reliability. Furthermore, every batch undergoes third-party quality testing to verify purity, composition, and overall quality. These comprehensive quality control measures help maintain the high standards required for research applications, providing researchers with a reliable compound for experimental use.
Certificate of Analysis
Each batch of our product is accompanied by a Certificate of Analysis (COA) issued by an independent third-party laboratory, verifying its purity and composition. This documentation provides an additional layer of transparency and quality assurance, ensuring that every product meets rigorous research standards. As a result, researchers can have greater confidence in the consistency, reliability, and integrity of the compounds used in their work. Product: Tirzepatide
Purity: 99%
Method: HPLC
Status: Passed
Molecular Information
Molecular formula: C₂₂₅H₃₄₈N₅₈O₆₈
Molecular weight: 4813.5 g/mol
Purity: 99%
Storage: Freezer at -20°C (lyophilized form)